Novel GC-rich DNA-binding compound produced by a genetically engineered mutant of the mithramycin producer Streptomyces argillaceus exhibits improved transcriptional repressor activity: implications for cancer therapy -- Albertini et al. 34 (6): 1721 Data Supplement - Supplementary Data -- Nucleic Acids Research

Novel GC-rich DNA-binding compound produced by a genetically engineered mutant of the mithramycin producer Streptomyces argillaceus exhibits improved transcriptional repressor activity: implications for cancer therapy
Nucl. Acids Res. Albertini et al. 34: 1721

Supplementary Data

Files in this Data Supplement:

Supplementary Material 1
Supplementary Material 2
Supplementary Material 3
Dataset 1
Dataset 2